Exchange: NASDAQ·Updated 06:32 AM EDT
KTTA logo

KTTA Pasithea Therapeutics Corp

$0.5804
$0.00
(0.00%)
Pre-Market
Prev Close $0.5804
Mkt Cap$19.39M
Vol228.00

About KTTA

Pasithea Therapeutics Corp. is a biotechnology company focused on the research and discovery of new and treatments for psychiatric and neurological disorders. The company was founded by Yassine Bendiabdallah and Lawrence J. Steinman on May 12, 2020 and is headquartered in Miami Beach, FL.
49

Neutral Sentiment

How do you feel about KTTA?

Advertisement|Remove ads.